Chinese medical team helps Zimbabwe complete country’s first neuromodulation surgeries

Zimbabwe has successfully performed its inaugural Deep Brain Stimulation (DBS) and Spinal Cord Stimulation (SCS) procedures, marking a significant leap in its capacity to treat complex neurological disorders. Conducted on May 28 and 29, 2026, the pioneering surgeries were led by Zimbabwean neurosurgeon Dr. Nathaniel Zimani, with critical technical support from Chinese chief surgeon Dr. Chen Yanliang. Both patients are reportedly in stable condition, signifying a breakthrough that positions Zimbabwe as only the second nation in Southern Africa to offer such advanced neuromodulation therapies. This medical milestone is a direct outcome of a sustained collaboration between Zimbabwe's Ministry of Health and Child Care and China's medical aid initiatives, specifically leveraging technology developed by Tsinghua University and commercialized by Beijing PINS Medical Co. The deployment of this Chinese-made neuromodulation equipment in Africa for the first time underscores Beijing's growing influence in global health infrastructure, providing a more affordable alternative to Western systems. The procedures address a critical gap, as Zimbabwean patients previously endured prohibitive costs and logistical hurdles to seek these specialized treatments abroad. The successful operations are expected to catalyze broader access to advanced neurological care across Zimbabwe, reducing the burden on patients and bolstering local medical expertise. With the 23rd Chinese medical team currently on a one-year mission in the country, the focus now shifts to embedding these capabilities through ongoing training and clinical exchanges. This ongoing partnership highlights China's long-term strategy of health diplomacy in Africa, aiming to build sustainable local medical capacity for complex conditions like Parkinson's disease, dystonia, and chronic pain.